A Very Nice Surprise TodayWhile the number of shares traded was still a relatively small fraction of the total no. of outstanding shares it was great to see that there is some growing interest. While shrooms (psilocybin) is getting a lot of attention there are already some potential drawbacks. Having said that the evolution of micro dosing hallucinogens is definitely still in its infancy with much research and drug policy change on the horizon.
That todays blip occurred without an associated NR could bode well should the impending news results be promising.
GLTE!!!